使用基于光的系统进行敏捷训练对帕金森病患者平衡和功能表现的影响
Thelma Rut Holmarsdottir1, Andri Thor Sigurgeirsson1, Atli Agustsson1
1Research Centre of Rehabilitation and Movement Science, Department of Physical Therapy, Faculty of Medicine, University of Iceland, 102 Reykjavík, Iceland.
Healthcare (Basel, Switzerland)
|October 29, 2025
概括
基于光的敏捷训练改善了帕金森病 (PD) 患者的平衡和转动能力. 这项为期四周的干预显示出高动机,但没有显著影响一般的移动性或行走速度.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 康复科学 康复科学 康复科学
背景情况:
- 帕金森病 (PD) 通常是由于勃拉迪基尼西亚和低运动症导致平衡和运动能力受损的原因.
- 患PD患者的冷漠可能会阻碍参与传统的培训计划.
- 最初针对运动员的基于光的敏捷训练可能为PD康复提供了一个激励的替代方案.
研究的目的:
- 调查为期四周的基于光的敏捷训练计划对帕金森病患者的平衡和一般移动性的影响.
- 评估这种新型培训方法在PD患者群体中的动机特性.
主要方法:
- 进行了一项没有对照组的纵向干预研究.
- 参与了7名患有PD的性-刚性亚型的人.
- 培训包括四周的三次每周的会议,每次有五轮的关灯;平衡和流动性在干预前后被评估.
主要成果:
- 在整体平衡,反应性姿势控制,感官定向和动态步态 (p < 0.001) 中观察到显著改善.
- 转动能力有所改善,但一般移动性,转移技能和步行速度没有.
- 在整个培训计划中,参与者的动机始终保持在高水平.
结论:
- 一个为期四周的基于光的敏捷训练计划可以提高帕金森病患者的平衡和转动能力.
- 这项培训似乎对患有PD的个人来说是非常激励的.
- 需要对更大的样本和对照组进行进一步的研究,以确认对一般流动性和步行速度的影响.
相关概念视频
01:24Parkinson's Disease: Treatment
970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K